Cytogenetic and molecular genetic characterization of a chromosome 2 rearrangement in a case of human papillary thyroid carcinoma with radiation history

Cancer Genetics and Cytogenetics

Volumn 96, Issue 1, 1997, Pages 30-36

  Lehmann, Lars ^a   Greulich, Karin M ^d   Zitzelsberger, Horst ^a,b   Negele, Thomas ^c   Spelsberg, Fritz ^c   Bauchinger, Manfred ^a   Weier, Heinz Ulrich G ^d  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Martha und Maria Helfen Krankenhaus Munchen   (Germany)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 2; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME REARRANGEMENT; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA;

ADULT; CARCINOMA, PAPILLARY; CHROMOSOMES, ARTIFICIAL, YEAST; CHROMOSOMES, HUMAN, PAIR 2; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INVERSION, CHROMOSOME; MALE; POLYMERASE CHAIN REACTION; THYROID NEOPLASMS;

EID: 0030919622     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(96)00279-8     Document Type: Article

References (35)

1. Silverberg E, Lubera TA (1989): Cancer statistics, 1989. CA Cancer J Clin 39:3-20.
2. Silverberg E, Boring CC, Squires TS (1990): Cancer statistics, 1990. CA Cancer J Clin 40:9-26.
3. Hedinger C, Williams ED, Sobin LH (1988): Histological Typing of Thyroid Tumors. WHO International Histological Classification of Tumours. Springer, Berlin.
4. Hay ID (1990): Papillary thyroid carcinoma. Clin Endocrinol Metab North Am 19:545-576.
5. De Besi P, Busnardo B, Toso S, Girelli ME, Nacamulli D, Simoni N, Casara D, Zorat P, Florentino MV (1991): Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer. J Endocrinol Invest 14:475-480.
6. Salvesen H, Njolstad PR, Akslen LA, Albrektsen G, Viste A, Soreide O, Varhaug JE (1991): Thyroid carcinoma: results from surgical treatment in 211 consecutive patients. Eur J Surg 157:521-526.
7. Staunton MD, Bourne H (1992): Malignant thyroid tumors 1932 to 1972: the outcome in 492 patients. Eur J Surg Oncol 18:469-474.
8. Bongarzone I, Pierotti MA, Monzini N, Mondellini P, Manenti G, Donghi R, Pilotti S, Grieco M, Santoro M, Fusco AM, Vecchio G, Della Porta G (1989): High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 4:1457-1462.
9. Santoro M, Carlomagno F, Hay ID, Hermann MA, Grieco M, Melillo R, Pierotti MA, Bongarzone I, Della Porta G, Berger N, Peix JL, Paulin C, Fabien N, Vecchio G, Jenkins RB, Fusco A (1992): Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 89:1517-1522.
10. Sozzi G, Bongarzone I, Miozzo M, Carini CT, Mondellini P, Calderone C, Pilotti S, Pierotti MA, Della Porta G (1992): Cytogenetic and molecular genetic characterisation of papillary thyroid carcinomas. Genes Chromosom Cancer 5:212-218.
11. Jhiang SM, Mazzaferri EL (1994): The RET/PTC oncogene in papillary thyroid carcinoma. J Lab Clin Med 123:331-337.
12. Bongarzone I, Monzini N, Borrello MG, Carcano C, Ferraresi G, Arighi E, Mondellini P, Della Porta G, Pierotti MA (1993): Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI of cyclic AMP protein kinase A. Mol Cell Biol 13:358-366.
13. Weier HUG, Rhein AP, Shadravan F, Collins C, Polikoff D (1995): Rapid physical mapping of the human TRK protooncogene (NTRK1) gene to human chromosome 1q21-22 by P1 clone selection, fluorescence in situ hybridization (FISH) and computer-assisted microscopy. Genomics 26:390-393.
14. Ishizaka Y, Kobayashi S, Ushijima T, Hirohashi S, Sugimura T, Nagao M (1991): Detection of ret TPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene 6:1667-1672.
15. Jhiang SM, Caruso DR, Gilmore E, Ishizaka Y, Tahira T, Nagao M, Chiu IM, Mazzaferri EL (1992): Detection of the PTC/RET oncogene in human thyroid cancers. Oncogene 7:1331-1337.
16. Zou MJ, Shi YF, Farid NR (1994): Low rate of ret proto-oncogene activation (PTC/RET) in papillary thyroid carcinomas from Saudi Arabia. Cancer 73:176-180.
17. Fabien N, Paulin C, Santoro M, Berger N, Grieco M, Galvain D, Barbier Y, Dubois PM, Fusco A (1992): Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation. Br J Cancer 66:1094-1098.
18. Hermanek P, Sobin LH (1987): UICC: TNM Classification of Malignant Tumours. Springer, Berlin.
19. ISCN (1995): An International System for Human Cytogenetic Nomenclature. F. Mitelman, ed. S. Karger, Basel.
20. Maniatis T, Fritsch E, Sambrook J (1982): Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, New York.
21. Kallioniemi A. Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992): Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
22. Johnson GD, de C Nogueira Araujo, GM (1981): A simple method of reducing the fading of immunofluorescence during microscopy. J Immunolog Methods 43:349-350.
23. Sherman F, Fink GR, Hicks JB (1986): Laboratory Course Manual for Methods in Yeast Genetic. Cold Spring Harbor Laboratory, New York.
24. Weier HUG, Rosette C, Matsuta M, Zitzelsberger H, Matsuta M, Gray JW (1994): Generation of highly specific DNA hybridization probes for chromosome enumeration in human interphase cell nuclei: isolation and enzymatic synthesis of alpha satellite DNA probes for chromosome 10 by primer directed DNA amplification. Meth Mol Cell Biol 4:231-248.
25. Lee ST, Strunk KM, Spritz RA (1993): A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. Oncogene 8:3403-3410.
26. Jenkins RB, Hay ID, Herath JF, Schultz CG, Spurbeck JL, Grant CS, Goellner JR, Dewald GW (1990): Frequent occurence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer 66:1213-1220.
27. Hermann ME, Talpos GB, Mohamed AN, Saxe A, Ratner S, Lalley PA, Wolman SR (1991): Genetic markers in thyroid tumors. Surgery 110:941-947.
28. Hermann ME, Lalley PA (1992): Significance of trisomy 7 in thyroid tumors. Cancer Genet Cytogenet 62:144-149.
29. Antonini P, Vénuat AM, Caillou B, Berger R, Schlumberger M, Bernheim A, Parmentier C (1992): Cytogenetic studies on 19 papillary thyroid carcinomas. Genes Chromosom Cancer 5:206-211.
30. Pierotti MA, Santoro M, Jenkins RB, Sozzi G, Bongarzone I, Grieco M, Monzini N, Miozzo M, Hermann MA, Fusco A, Hay ID, Della Porta G, Vecchio G (1992): Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/ PTC. Proc Natl Acad Sci USA 89:1616-1620.
31. Fusco AM, Greco A, Santoro M, Berlingieri MT, Pilotti S, Pierotti MA, Della Porta G, Vecchio G (1987): A new oncogene in human papillary carninomas and their lymph-nodal metastases. Nature 328:170.
32. Santoro M, Dathan NA, Berlingieri MT, Bongarzone I, Paulin C, Grieco M, Pierotti MA, Vecchio G, Fusco A (1994): Molecular characterization of RET/PTC3; a novel rearranged version of the RET proto-oncogene in a human thyroid papillary carcinoma. Oncogene 9:509-516.
33. Ishizaka Y, Itho F, Tahisa T, Ikeda I, Sugimura T, Tucker J, Fertitta A, Carrano A, Nagao M (1989): Human ret proto-oncogene mapped to chromosome 10q11.2. Oncogene 4:1519-1521.
34. Greco A, Pierotti MA, Bongarzone I, Pagliardini S, Lanzi C, Della Porta G (1992): TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinoma. Oncogene 7:237-242.
35. Ito T, Seyama T, Iwamoto KS, Hayashi T, Mizuno T, Tsuyama N, Dohi K, Nakamura N, Akiyama M (1993): In vitro irradiation is able to cause RET oncogene rearrangement. Cancer Res 53:2940-2943.